VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AVNS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AVNSAvanos Medical, Inc.
$24.93$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAVNSQuarterly Financials

Avanos Medical, Inc. (AVNS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Avanos Medical, Inc. (AVNS) quarterly income statement — complete revenue, gross profit & net income history

AVNS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue182.2M180.9M177.8M175M167.5M179.6M170.4M171.7M166.1M173.3M171.3M169.4M159.3M181.6M172.3M170.9M197.4M193.4M184.1M186.4M
Revenue Growth %8.78%0.72%4.34%1.92%0.84%3.64%-0.53%1.36%4.27%-4.57%-0.58%-0.88%-19.3%-6.1%-6.41%-8.32%9.24%4.54%-0.86%13.87%
Cost of Goods Sold88M94.9M96.7M82.9M77.7M80.3M77.5M76.1M71.3M78.3M75.8M71.6M67.9M78.7M72.1M69.3M90.8M95.6M92.1M94.9M
COGS % of Revenue48.3%52.46%54.39%47.37%46.39%44.71%45.48%44.32%42.93%45.18%44.25%42.27%42.62%43.34%41.85%40.55%46%49.43%50.03%50.91%
Gross Profit94.2M86M81.1M92.1M89.8M99.3M92.9M95.6M94.8M95M95.5M97.8M91.4M102.9M100.2M101.6M106.6M97.8M92M91.5M
Gross Margin %51.7%47.54%45.61%52.63%53.61%55.29%54.52%55.68%57.07%54.82%55.75%57.73%57.38%56.66%58.15%59.45%54%50.57%49.97%49.09%
Gross Profit Growth %4.9%-13.39%-12.7%-3.66%-5.27%4.53%-2.72%-2.25%3.72%-7.68%-4.69%-3.74%-14.26%5.21%8.91%11.04%15.24%0.41%-7.72%5.78%
Operating Expenses5.2M175.3M68M84.8M82.5M86.8M76.2M79.5M87.4M72.8M70M86M85.9M85.5M85.2M89.8M93.5M78.6M80.3M76.3M
OpEx % of Revenue2.85%96.9%38.25%48.46%49.25%48.33%44.72%46.3%52.62%42.01%40.86%50.77%53.92%47.08%49.45%52.55%47.37%40.64%43.62%40.93%
Selling, General & Admin077.7M62.2M79M77.1M81.1M69M73.2M80.4M66M63.9M79.2M78.4M78.3M78.1M82.2M85.7M71M71.9M68.3M
SG&A % of Revenue-42.95%34.98%45.14%46.03%45.16%40.49%42.63%48.4%38.08%37.3%46.75%49.22%43.12%45.33%48.1%43.41%36.71%39.05%36.64%
Research & Development5.2M6.1M5.8M5.8M5.4M5.7M7.2M6.3M7M6.8M6.1M6.8M7.9M7.5M7.3M8M7.8M7.6M8.4M8M
R&D % of Revenue2.85%3.37%3.26%3.31%3.22%3.17%4.23%3.67%4.21%3.92%3.56%4.01%4.96%4.13%4.24%4.68%3.95%3.93%4.56%4.29%
Other Operating Expenses01000K000000000000000000
Operating Income8.9M-89.3M13.1M7.3M7.3M12.5M16.7M16.1M7.4M22.2M25.5M11.8M5.5M17.4M15M11.8M13.1M19.2M11.7M15.2M
Operating Margin %4.88%-49.36%7.37%4.17%4.36%6.96%9.8%9.38%4.46%12.81%14.89%6.97%3.45%9.58%8.71%6.9%6.64%9.93%6.36%8.15%
Operating Income Growth %21.92%-814.4%-21.56%-54.66%-1.35%-43.69%-34.51%36.44%34.55%27.59%70%0%-58.02%-9.38%28.21%-22.37%18.02%-46.81%-27.33%-11.63%
EBITDA19.1M-79.4M22.5M17.3M16.9M23.6M28.4M27.4M18.8M33.7M36.5M22.1M16.2M28.8M25M21.9M24.2M28.7M21.3M24.7M
EBITDA Margin %10.48%-43.89%12.65%9.89%10.09%13.14%16.67%15.96%11.32%19.45%21.31%13.05%10.17%15.86%14.51%12.81%12.26%14.84%11.57%13.25%
EBITDA Growth %13.02%-436.44%-20.77%-36.86%-10.11%-29.97%-22.19%23.98%16.05%17.01%46%0.91%-33.06%0.35%17.37%-11.34%16.35%-38.81%-20.52%-11.79%
D&A (Non-Cash Add-back)10.2M9.9M9.4M10M9.6M11.1M11.7M11.3M11.4M11.5M11M10.3M10.7M11.4M10M10.1M11.1M9.5M9.6M9.5M
EBIT03.1M600K-73.9M11.8M-417.7M12.7M9.3M4.6M12.2M2.1M-1.6M-5.6M17.3M13.1M10.3M8.6M25M3.8M-7.3M
Net Interest Income0-1.3M-1.3M-1.4M-600K-2M-2.5M-100K-2.5M-2.3M-3.8M-3M-3M-2.3M-2.7M-2.5M-1.3M-700K-700K-900K
Interest Income200K600K500K600K1.5M800K700K3M600K1M900K500K500K700K300K200K00200K0
Interest Expense-1.5M1.9M1.8M2M2.1M2.8M3.2M3.1M3.1M3.3M4.7M3.5M3.5M3M3M2.7M1.3M700K900K900K
Other Income/Expense-1.3M90.5M-14.3M-83.2M2.4M-433M-7.2M-9.9M-5.9M-13.3M-28.1M-16.9M-14.6M-3.1M-4.9M-4.2M-5.8M5.1M-8.8M-23.4M
Pretax Income7.6M1.2M-1.2M-75.9M9.7M-420.5M9.5M6.2M1.5M8.9M-2.6M-5.1M-9.1M14.3M10.1M7.6M7.3M24.3M2.9M-8.2M
Pretax Margin %4.17%0.66%-0.67%-43.37%5.79%-234.13%5.58%3.61%0.9%5.14%-1.52%-3.01%-5.71%7.87%5.86%4.45%3.7%12.56%1.58%-4.4%
Income Tax-2.5M-2.5M200K900K3.1M-23.5M3.6M1.9M1M-2.1M6.2M-800K-1.3M4.6M-900K2.8M1.9M14.3M38M-46.1M
Effective Tax Rate %-32.89%-208.33%-16.67%-1.19%31.96%5.59%37.89%30.65%66.67%-23.6%-238.46%15.69%14.29%32.17%-8.91%36.84%26.03%58.85%1310.34%562.2%
Net Income5.1M3.7M-1.4M-76.8M6.6M-397.3M4.3M1.8M-900K10.5M-3.7M-68.1M-500K16.9M15.7M12.5M5.4M10M-35.1M37.9M
Net Margin %2.8%2.05%-0.79%-43.89%3.94%-221.21%2.52%1.05%-0.54%6.06%-2.16%-40.2%-0.31%9.31%9.11%7.31%2.74%5.17%-19.07%20.33%
Net Income Growth %-22.73%100.93%-132.56%-4366.67%833.33%-3883.81%216.22%102.64%-80%-37.87%-123.57%-644.8%-109.26%69%144.73%-67.02%171.05%121.19%-281.87%1363.33%
Net Income (Continuing)5.1M3.7M-1.4M-76.8M6.6M-397M5.9M4.3M500K11M-8.8M-4.3M-7.8M9.7M11M4.8M5.4M10M-35.1M37.9M
Discontinued Operations00000-300K-1000K-1000K-1000K-500K1000K-1000K1000K1000K1000K1000K0000
Minority Interest00000000000000000000
EPS (Diluted)0.110.08-0.03-1.660.14-8.640.090.04-0.020.23-0.08-1.46-0.010.360.330.240.120.21-0.730.78
EPS Growth %-21.43%100.92%-132.72%-4334.69%817.95%-3856.52%216.69%102.68%-82.24%-36.11%-123.97%-708.33%-108.92%71.43%145.21%-69.23%175%121.21%-282.5%1342.04%
EPS (Basic)0.110.08-0.03-1.660.14-8.640.090.04-0.020.23-0.08-1.46-0.010.360.340.240.120.21-0.730.79
Diluted Shares Outstanding46.4M46.4M46.4M46.8M46.8M46M46.6M46.3M46.2M46.6M46.8M46.8M46.6M47M47M47.6M47.8M48.6M48.1M48.6M
Basic Shares Outstanding46.4M46.4M46.4M46.1M46.1M46M46M45.9M46.2M46.2M46.8M46.8M46.6M46.5M46.6M47.2M47.4M48.2M48.1M48.1M
Dividend Payout Ratio--------------------